APDA Center for Advanced Research
Mayo Clinic's campus in Jacksonville, Florida, is home to a Center for Advanced Research supported by the American Parkinson Disease Association (APDA). The center is directed by Dennis Dickson, M.D., and Pamela McLean, Ph.D., who work with a comprehensive team of experts.
APDA Centers for Advanced Research must meet the highest academic standards and be distinguished leaders in the field of PD research. There are eight such centers across the country.
The funding of this center supports a large research program, which includes:
- Basic research laboratories studying disease pathogenesis
- Clinical studies of PD and related movement disorders
- Genetic studies of PD and related movement disorders
- Brain banking and neuropathological studies
- Biofluid biobanking (plasma and CSF) from PD patients and controls
These activities are supported by established and internationally recognized researchers and movement disorder clinicians, as well as junior scientists, postdoctoral trainees, graduate students, and visiting scientists.
The Mayo Clinic Jacksonville APDA Center for Advanced Research synergizes with the existing Mayo Clinic APDA Parkinson's disease Information and Referral Center.
The center is affiliated with numerous Mayo Clinic researchers and research entities.
A team effort in the fight against Parkinson's disease
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson's disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $170 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson's disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at www.apdaparkinson.org.
Parkinson's disease affects more than 1 million people in the United States annually, with at least 60,000 new cases diagnosed each year. The chronic and progressive neurological condition is the second most common neurodegenerative aging disorder, after Alzheimer's disease.
For more information, contact: